| A Immunogenicity and Safety Trial of the Recombinant Zoster Vaccine （CHO Cell）, LYB004 in Adults Aged 40 Years and Older (NCT07311148) | Guangzhou Patronus Biotech Co., Ltd. | 2025-10-23 |
| A Study to Evaluate the Immunogenicity and Safety of a Recombinant Respiratory Syncytial Virus Vaccine in Older Adults Aged 60 Years and Older (NCT07208461) | Guangzhou Patronus Biotech Co., Ltd. | 2025-10-21 |
| Safety and Immunogenicity of the Recombinant Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 18 Years and Older (NCT06904222) | Guangzhou Patronus Biotech Co., Ltd. | 2025-04-15 |
| Safety and Immunogenicity of the Recombinant Zoster Vaccine, LYB004 in Adults Aged 40 Years and Older (NCT06874842) | Guangzhou Patronus Biotech Co., Ltd. | 2025-03-13 |
| A Safety and Immunogenicity Trial of a Respiratory Syncytial Virus Vaccine, LYB005 in Healthy Adults (NCT06442241) | Guangzhou Patronus Biotech Co., Ltd. | 2024-07-31 |
| Safety and Immunogenicity of Recombinant COVID-19 Trivalent Protein Vaccine （CHO Cell）LYB002V14 in Booster Vaccination (NCT06167915) | Guangzhou Patronus Biotech Co., Ltd. | 2023-12-26 |
| The Safety and Immunogenicity Following a Heterologous Booster Dose of Recombinant SARS-CoV-2 Vaccine LYB002 (NCT05928468) | Guangzhou Patronus Biotech Co., Ltd. | 2023-04-25 |
| Immunogenicity and Safety of COVID-19 Vaccine in Population Aged 18 Years and Above (NCT05663086) | Guangzhou Patronus Biotech Co., Ltd. | 2023-01-07 |
| Efficacy and Safety of COVID-19 Vaccine as Booster Vaccination in Adults 18 Years of Age or Older (NCT05683600) | Guangzhou Patronus Biotech Co., Ltd. | 2022-12-29 |
| Immunogenicity and Safety of COVID-19 Vaccine as a Booster Vaccination in Population Aged 18 Years and Above (NCT05664932) | Guangzhou Patronus Biotech Co., Ltd. | 2022-12-28 |
| Safety and Immunogenicity of COVID-19 Vaccine in Population Aged 18 Years and Above (NCT05552573) | Guangzhou Patronus Biotech Co., Ltd. | 2022-07-19 |
| The Immunogenicity and Safety Following a Heterologous Booster Dose of Recombinant SARS-CoV-2 Vaccine LYB001 (NCT05928455) | Guangzhou Patronus Biotech Co., Ltd. | 2022-05-14 |